Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03334617 |
|---|---|
| Brief Title: | Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy (HUDSON) |
| First Submitted : | September 22, 2017 |
| First Submitted that Met QC Criteria : | November 3, 2017 |
| First Posted : | November 7, 2017 |
| Last Update Submitted that Met QC Criteria : | January 4, 2023 |
| Last Update Posted : | January 5, 2023 |